PYNG TECHNOLOGIES CORP.
NEWS RELEASE
September 27, 1999
PYT.V
OTC.BB-PYNGF
PYNG MEDICAL LAUNCHES INTERNATIONAL MARKETING FOR
F.A.S.T.1 SYSTEM FOR ADULT INTRAOSSEOUS INFUSION
Pyng Technologies announced today that subsidiary Pyng Medical Corp has retained the exclusive services of Mr.
Paul Mathias, as International Marketing Consultant. Mr. Mathias task will be to define and implement a
comprehensive marketing plan in the critical product launch stages of commercializing the F.A.S.T.1 System for
Adult Intraosseous Infusion.
As an exclusive International Marketing Consultant to Pyng, Paul Mathias brings over 17 years of marketing and
sales management experience in the medical device industry with such companies as Johnson and Johnson, Baxter
International, and Xillix. Mr. Mathias will utilize all of his considerable skills to grow international product revenues
for the F.A.S.T.1 System through partner organizations in the United States, Europe, Japan and Asia.
As the exclusive International Marketing Consultant, Mr. Mathias will be responsible for working with
management to develop and implement global marketing, sales and distribution plans for the imminent release of
the F.A.S.T.1 System for Adult Intraosseous Infusion. This coincides with Pyng Medical Corp. recent news
release that it has signed a production contract for the F.A.S.T.1 System with Comptec International.
Commenting on the additional marketing support, Michael W. Jacobs, President of Pyng noted, " As we transition
from the development stages to the commercialization stages with the F.A.S.T. 1 System we are pleased to have
access to Paul’s international knowledge and experience in marketing medical devices". Pyng Medical
Corp. and Mr. Paul Mathias mutually agree that there will be an option to convert this exclusive consulting roll to
the position of Vice-President of International Marketing, with involvement on the executive board of Pyng
Medical Corp., if satisfactory goals are met.
Pyng Technologies is the world leader in the development of Sternal Access Adult Intraosseous Infusion Systems.
The F.A.S.T.1 System is a patented, life saving technology for the infusion of volume replacement fluids and
medications with applications in emergency response, hospital and military markets. The FDA in the USA and the
HPB in Canada have cleared the F.A.S.T. 1 System to market.
For further information please contact Michael W. Jacobs, President at 1-800-349-7964 or visit our web site at
www.pyng.com
The VSE has neither reviewed or approved of the contents of this news release.
Stang |
